The post Kalshi Partners with Luxury Watch Marketplace Bezel appeared on BitcoinEthereumNews.com. The partnership with the CFTC-regulated prediction market willThe post Kalshi Partners with Luxury Watch Marketplace Bezel appeared on BitcoinEthereumNews.com. The partnership with the CFTC-regulated prediction market will

Kalshi Partners with Luxury Watch Marketplace Bezel

2026/03/04 00:23
Okuma süresi: 2 dk
Bu içerikle ilgili geri bildirim veya endişeleriniz için lütfen crypto.news@mexc.com üzerinden bizimle iletişime geçin.

The partnership with the CFTC-regulated prediction market will let users bet on luxury watch prices.

Kalshi, the largest prediction market platform by monthly spot volumes, has unveiled a strategic partnership with Bezel, a specialist in authenticated luxury watches, to let Kalshi users bet on the prices of luxury watches. Kalshi announced the move in an X post today, March 3.

The partnership with Bezel is part of Kalshi’s broader strategy to enhance its offerings in the collectibles market, Bloomberg reported today, citing executives from both firms.

Bezel’s CEO and co-founder, Quaid Walker, told Bloomberg that watches have “been viewed as a financial market for a really long period of time, but it’s also passion-driven.”

Kalshi’s previous moves into collectibles markets include a recent partnership with StockX, platform for trading physical collectibles, from trading cards to sneakers and other apparel and accessories.

Today’s announcement comes as the hybrid on-off-chain platform had its bst month yet, surpassing on-chain prediction marketplace Polymarket in monthly trading volumes for the sixth consecutive month with $9.8 billion in trades in February, per data from Artemis.

Polymarket saw just under $8 million last month, while total sector volume was down month over month for the first time since last August, as BNB Chain-based rival Opinion recorded a massive drop.

Kalshi and Polymarket have been neck and neck in recent months, both in terms of trading volumes and valuations, after their most recent funding rounds.

Prediction market monthly spot volumes. Source: Artemis

The prediction market industry is navigating complex legal landscapes, with platforms like Kalshi and Polymarket under scrutiny — including in the United States, where both platforms now operate as regulated entities under the Commodity Futures Trading Commission (CFTC).

As The Defiant reported, last month, the CFTC took a strong public stance on the issue, arguing that that the agency, not individual states, should regulate prediction market platforms.

This article was generated with the assistance of AI workflows.

Source: https://thedefiant.io/news/nfts-and-web3/kalshi-partners-with-luxury-watch-marketplace-bezel

Piyasa Fırsatı
Blocksquare Token Logosu
Blocksquare Token Fiyatı(BST)
$0,0141
$0,0141$0,0141
-1,53%
USD
Blocksquare Token (BST) Canlı Fiyat Grafiği

SPACEX(PRE) Launchpad

SPACEX(PRE) LaunchpadSPACEX(PRE) Launchpad

Register for a chance to win a free lucky draw

Sorumluluk Reddi: Bu sitede yeniden yayınlanan makaleler, halka açık platformlardan alınmıştır ve yalnızca bilgilendirme amaçlıdır. MEXC'nin görüşlerini yansıtmayabilir. Tüm hakları telif sahiplerine aittir. Herhangi bir içeriğin üçüncü taraf haklarını ihlal ettiğini düşünüyorsanız, kaldırılması için lütfen crypto.news@mexc.com ile iletişime geçin. MEXC, içeriğin doğruluğu, eksiksizliği veya güncelliği konusunda hiçbir garanti vermez ve sağlanan bilgilere dayalı olarak alınan herhangi bir eylemden sorumlu değildir. İçerik, finansal, yasal veya diğer profesyonel tavsiye niteliğinde değildir ve MEXC tarafından bir tavsiye veya onay olarak değerlendirilmemelidir.

Ayrıca Şunları da Beğenebilirsiniz

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Paylaş
BitcoinEthereumNews2025/09/18 05:26
Bitcoin shorts risk $2.5 billion liquidation at $72K: Are bears in danger?

Bitcoin shorts risk $2.5 billion liquidation at $72K: Are bears in danger?

Bitcoin is poised for a reversal if ETF demand returns or a ceasefire occurs, potentially crushing short sellers in a massive price squeeze.
Paylaş
Coin Telegraph2026/04/04 19:58
Robotics Automation Prototyping: Engineering Kinetic Agility into End-Effectors

Robotics Automation Prototyping: Engineering Kinetic Agility into End-Effectors

Inertia is the invisible tax on modern industrial throughput. Every millisecond a robotic arm spends decelerating, or waiting for high-frequency vibrations to settle
Paylaş
Techbullion2026/04/02 18:25

RealStocks Now Live

RealStocks Now LiveRealStocks Now Live

Trade real U.S. stock via regulated brokerage